Financing ·
Waldencast plc announced two significant developments
WALDWaldencast plc
Waldencast plc announced two significant developments. On June 11, 2026, subsidiaries Milk Makeup LLC and Obagi Cosmeceuticals LLC entered into a Second Amendment to their Credit Agreement, which postpones the requirement to issue warrants for Term Tranche B Loans from July 1, 2026, to November 17, 2026. Additionally, on June 15, 2026, the company announced that Obagi Medical received FDA approval for Obagi® saypha® ChIQ™ Injectable Hyaluronic Acid Gel. Waldencast plc is a beauty and skincare company that operates through various brands including Obagi Medical and Milk Makeup.